GSK-J1,
GSK J1,
1373422-53-7,
GSKJ1,
3-{[2-(pyridin-2-yl)-6-(2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl)pyrimidin-4-yl]amino}propanoic acid,
3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid,
3-[[2-Pyridin-2-Yl-6-(1,2,4,5-Tetrahydro-3-Benzazepin-3-Yl)pyrimidin-4-Yl]amino]propanoic Acid,
GSKJ1; GSK-J1,
MLS006010249,
GTPL7027,
CHEMBL3188597,
SCHEMBL10157115,
BDBM60875,
AOB3940,
EX-A571,
CHEBI:131152,
BCP08262,
EX-A1744,
2442AH,
MFCD22683851,
s7581,
ZINC95616592,
AKOS024458240,
CS-3322,
GSK-J1, >=98% (HPLC),
SB19353,
NCGC00347943-01,
NCGC00347943-09,
AK316493,
AS-16773,
DA-45895,
HY-15648,
SMR004701325,
FT-0700180,
J-007002,
N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-?-alanine,
3-((2-(Pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoic acid,
3-(6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-ylamino)propanoic acid,
N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine,
N-[2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)pyrimidin-4-yl]-beta-alanine,
D0S3DD,
C22H23N5O2,
A12918,
K0I,